Accelsius Books $50M Q1 Orders and Backlog, Cash Up to $65.4M
Accelsius secured over $50 million in contracted backlog and $50 million in Q1 2026 bookings, reflecting institutional validation from Johnson Controls and Legrand. Innventure’s cash rose to $65.4 million at end-2025 from $11.1 million, while COGS relative to revenue climbed and AeroFlexx’s Aveda rollout timing remains uncertain.
1. Commercial Momentum at Accelsius
Accelsius reported over $50 million in contracted backlog and generated an additional $50 million in bookings during Q1 2026. These figures underscore a shift from pilot evaluations to commercial-scale orders, with key validations from Johnson Controls and Legrand driving demand.
2. Strengthened Cash Position
Innventure ended 2025 with $65.4 million in cash and equivalents, up from $11.1 million a year earlier. This boost provides a robust runway to fund ongoing operational expansion and technology commercialization.
3. Cost Structure and Revenue Recognition Challenges
The cost of goods sold as a percentage of revenue has risen, pressuring margins and highlighting the need for further efficiency improvements. Revenue recognition for Accelsius is expected to be heavily back-end weighted in 2026, complicating near-term forecasting.
4. AeroFlexx Partnership Uncertainties
AeroFlexx’s partnership with Aveda has advanced to commercial-sized proposals within a $30 million pipeline, but the timing and scale of annual volumes remain unclear. Final rollout dates and volume commitments have yet to be defined, introducing execution risk.